Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services

Core Insights - Codexis, Inc. has announced its first revenue-generating contract to manufacture siRNA material in its ECO Synthesis™ Innovation Lab, marking a significant milestone in its operations [1] - The company has successfully developed the first generation of its core ECO Synthesis™ enzymes, meeting criteria for scaling to industrial capacity [2] - CEO Stephen Dilly expressed excitement over the contract and highlighted the successful development of a suite of enzymes that can drive the ECO Synthesis™ platform at an industrial scale [3] Company Overview - Codexis is a leading provider of enzymatic solutions aimed at efficient and scalable therapeutics manufacturing, utilizing its proprietary CodeEvolver® technology platform [4] - The company is focused on developing its ECO Synthesis™ manufacturing platform to enable the large-scale production of RNAi therapeutics through an enzymatic route, which offers advantages such as higher yields and reduced energy usage [4]